Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia

NAEnrolling by invitationINTERVENTIONAL
Enrollment

2,250

Participants

Timeline

Start Date

September 30, 2026

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
COVID-19Vaccine Hesitancy
Interventions
BEHAVIORAL

Health Communication

Participants will experience a coordinated social marketing campaign including targeted messaging related to vaccine education, self-efficacy, and informative resources to receive the COVID-19 vaccine. The intervention messaging will be strategically layered and disseminated to this intervention arm predominately via Facebook by trusted and local communicators in the study counties.

BEHAVIORAL

Health Communication + Structural

This multi-level intervention will include the defined health messaging intervention components, as well as a combination of structural-level intervention strategies targeted to better facilitate access to community-based vaccination delivery. Health organizations will receive a toolkit, which will include community-specific resources and training modules such as: up to date evidence-based vaccination guidance that can be delivered to patients; strategies for navigating conversations with patients about vaccination; any applicable reimbursement, insurance, or qualifying enrollment information specific to the healthcare organization; identifying locations that facilitate access for the community members; provided advertising to promote the locations and timing of the vaccinations; and generating community-based branding for all vaccination delivery based on the trusted information sources identified.

Trial Locations (1)

41701

University of Kentucky Center of Excellence in Rural Health, Hazard

All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

Marc Kiviniemi

OTHER